| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant phosphorylation of STAT5 by granulocyte-macrophage colony-stimulating factor in infant cytomegalovirus infection mimicking juvenile myelomonocytic leukemia
|
Nishio, Nobuhiro
|
|
2011
|
35 |
9 |
p. 1261-1264
4 p.
|
artikel
|
| 2 |
Adaptation of the plasma inhibitory activity assay to detect Aurora, ABL and FLT3 kinase inhibition by AT9283 in pediatric leukemia
|
Podesta, Jennifer E.
|
|
2011
|
35 |
9 |
p. 1273-1275
3 p.
|
artikel
|
| 3 |
Advanced age and prognosis in chronic myeloid leukemia in the era of tyrosine kinase inhibitors
|
Stein, Brady L.
|
|
2011
|
35 |
9 |
p. 1161-1163
3 p.
|
artikel
|
| 4 |
Agranulocytosis in cocaine users in Ohio: Suspected levamisole taint
|
Herms, Benjamin
|
|
2011
|
35 |
9 |
p. e173-e174
nvt p.
|
artikel
|
| 5 |
CD7-positive acute myelomonocytic leukemia with trisomy 21 as a sole acquired chromosomal abnormality in two adolescents
|
Kudo, Ko
|
|
2011
|
35 |
9 |
p. e167-e168
nvt p.
|
artikel
|
| 6 |
Chromosomal translocation t(1;9)(q24;q34) in acute lymphoblastic leukemia patient involving the ABL1 gene
|
Zámečníkova, Adriana
|
|
2011
|
35 |
9 |
p. e149-e150
nvt p.
|
artikel
|
| 7 |
Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: Is that true for all the patients?
|
Eskazan, Ahmet Emre
|
|
2011
|
35 |
9 |
p. e145-e146
nvt p.
|
artikel
|
| 8 |
Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox
|
Nolte, Florian
|
|
2011
|
35 |
9 |
p. 1131-1135
5 p.
|
artikel
|
| 9 |
Clinical usefulness of plasma specimens for detection of nucleophosmin 1 gene mutations in patients with normal karyotype acute myeloid leukemia
|
Park, Sang Hyuk
|
|
2011
|
35 |
9 |
p. e159-e160
nvt p.
|
artikel
|
| 10 |
Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one?
|
Thanendrarajan, Sharmilan
|
|
2011
|
35 |
9 |
p. 1136-1142
7 p.
|
artikel
|
| 11 |
Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma
|
de Brito, Luis R.
|
|
2011
|
35 |
9 |
p. 1233-1240
8 p.
|
artikel
|
| 12 |
Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib
|
Latagliata, Roberto
|
|
2011
|
35 |
9 |
p. 1164-1169
6 p.
|
artikel
|
| 13 |
Deletion of TET2 gene in an acute myeloid leukemia case with a t(4;15)(q24;q26) characterized by glass needle based chromosome microdissection and oligonucleotide array
|
Villa, Olaya
|
|
2011
|
35 |
9 |
p. e161-e163
nvt p.
|
artikel
|
| 14 |
Early and mature endothelial progenitors and VEGFR2+-cells in multiple myeloma: Association with disease characteristics and variation in different cell compartments
|
Udi, Josefina
|
|
2011
|
35 |
9 |
p. 1265-1268
4 p.
|
artikel
|
| 15 |
Editorial Board
|
|
|
2011
|
35 |
9 |
p. CO2-
1 p.
|
artikel
|
| 16 |
Effects of exogenous agmatine in human leukemia HMC-1 and HL-60 cells on proliferation, polyamine metabolism and cell cycle
|
Haenisch, Britta
|
|
2011
|
35 |
9 |
p. 1248-1253
6 p.
|
artikel
|
| 17 |
Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation
|
Nomdedeu, Meritxell
|
|
2011
|
35 |
9 |
p. 1276-1278
3 p.
|
artikel
|
| 18 |
Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2′-deoxycytidine
|
Dubovsky, Jason A.
|
|
2011
|
35 |
9 |
p. 1193-1199
7 p.
|
artikel
|
| 19 |
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study
|
Sánchez-Guijo, Fermin M.
|
|
2011
|
35 |
9 |
p. 1184-1187
4 p.
|
artikel
|
| 20 |
Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion
|
Hadiji Mseddi, Sondes
|
|
2011
|
35 |
9 |
p. e175-e176
nvt p.
|
artikel
|
| 21 |
Heat shock protein 90 (HSP90) inhibition in acute myeloid leukemia—Targeting of disease heterogeneity through direct and indirect antileukemic effects
|
Bruserud, Øystein
|
|
2011
|
35 |
9 |
p. 1156-1158
3 p.
|
artikel
|
| 22 |
Heat shock protein 90 inhibition results in altered downstream signaling of mutant KIT and exerts synergistic effects on Kasumi-1 cells when combining with histone deacetylase inhibitor
|
Yu, Wenjuan
|
|
2011
|
35 |
9 |
p. 1212-1218
7 p.
|
artikel
|
| 23 |
High-grade solitary extramedullary plasmacytoma arising in skeletal muscle of a kidney transplant recipient
|
Bidros, Michel
|
|
2011
|
35 |
9 |
p. e181-e183
nvt p.
|
artikel
|
| 24 |
Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide
|
Cibeira, María Teresa
|
|
2011
|
35 |
9 |
p. 1178-1183
6 p.
|
artikel
|
| 25 |
Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma
|
Nguyen-Pham, Thanh-Nhan
|
|
2011
|
35 |
9 |
p. 1241-1247
7 p.
|
artikel
|
| 26 |
Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine+cytarabine
|
Knoebel, Randall W.
|
|
2011
|
35 |
9 |
p. e164-e166
nvt p.
|
artikel
|
| 27 |
Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells
|
Tanaka, Norina
|
|
2011
|
35 |
9 |
p. 1219-1225
7 p.
|
artikel
|
| 28 |
MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia
|
Gao, Xiao-ning
|
|
2011
|
35 |
9 |
p. 1226-1232
7 p.
|
artikel
|
| 29 |
Molecular response to first line nilotinib in a patient with e19a2 BCR–ABL1 chronic myeloid leukemia
|
Langabeer, Stephen E.
|
|
2011
|
35 |
9 |
p. e169-e170
nvt p.
|
artikel
|
| 30 |
Mutational analysis of RUNX1T1 gene in acute leukemias, breast and lung carcinomas
|
Kim, Yoo Ri
|
|
2011
|
35 |
9 |
p. e157-e158
nvt p.
|
artikel
|
| 31 |
Nilotinib and dasatinib first-line: Are we ready for imatinib replacement?
|
Breccia, Massimo
|
|
2011
|
35 |
9 |
p. 1153-1155
3 p.
|
artikel
|
| 32 |
Numb chin syndrome: A warning sign of aggressive B-cell malignancy
|
López-Cortés, Luis Eduardo
|
|
2011
|
35 |
9 |
p. e177-e178
nvt p.
|
artikel
|
| 33 |
Pneumocystis jirovecii pneumonia as first manifestation of late relapse angioimmunoblastic T-cell lymphoma
|
García-Noblejas, Ana
|
|
2011
|
35 |
9 |
p. e143-e144
nvt p.
|
artikel
|
| 34 |
PRAME: From diagnostic marker and tumor antigen to promising target of RNAi therapy in leukemic cells
|
Yin, Bu
|
|
2011
|
35 |
9 |
p. 1159-1160
2 p.
|
artikel
|
| 35 |
Predictability of the response to tyrosine kinase inhibitors via in vitro analysis of Bcr-Abl phosphorylation
|
Shibata, Masaru
|
|
2011
|
35 |
9 |
p. 1205-1211
7 p.
|
artikel
|
| 36 |
Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate
|
Yoon, Ju-Yoon
|
|
2011
|
35 |
9 |
p. e179-e180
nvt p.
|
artikel
|
| 37 |
Specific killing of CCR9 high-expressing acute T lymphocytic leukemia cells by CCL25 fused with PE38 toxin
|
Hu, Yi
|
|
2011
|
35 |
9 |
p. 1254-1260
7 p.
|
artikel
|
| 38 |
Subcutaneous panniculitis-like T-cell lymphoma-associated hemophagocytic syndrome with fulminant relapse during corticosteroid treatment and fatal outcome
|
Voelkl, Andreas
|
|
2011
|
35 |
9 |
p. e154-e156
nvt p.
|
artikel
|
| 39 |
Sustained trilineage hematopoietic recovery in a patient with refractory anemia, del(13)(q12q22), and paroxysmal nocturnal hemoglobinuria-type cells treated with immunosuppressive therapy
|
Kasahara, Ikumi
|
|
2011
|
35 |
9 |
p. e147-e148
nvt p.
|
artikel
|
| 40 |
t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: Report of a case treated with sorafenib and review of the literature
|
Wakim, Jad J.
|
|
2011
|
35 |
9 |
p. e151-e153
nvt p.
|
artikel
|
| 41 |
The clonogenic potential of selected CD34+ cells from patients with MDS appear preserved when tested ex vivo
|
Davison, Glenda Mary
|
|
2011
|
35 |
9 |
p. 1200-1204
5 p.
|
artikel
|
| 42 |
The efficacy and safety of arsenic trioxide with or without all-trans retinoic acid for the treatment of acute promyelocytic leukemia: A meta-analysis
|
Wang, Hao
|
|
2011
|
35 |
9 |
p. 1170-1177
8 p.
|
artikel
|
| 43 |
The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma
|
Demirkesen, Cuyan
|
|
2011
|
35 |
9 |
p. 1269-1272
4 p.
|
artikel
|
| 44 |
The t(11;19)(q23;p13) fusing MLL with MYO1F is recurrent in infant acute myeloid leukemias
|
Duhoux, Francois P.
|
|
2011
|
35 |
9 |
p. e171-e172
nvt p.
|
artikel
|
| 45 |
Translocation t(1;9) is a recurrent cytogenetic abnormality associated with progression of essential thrombocythemia patients displaying the JAK2 V617F mutation
|
Leon, Annette
|
|
2011
|
35 |
9 |
p. 1188-1192
5 p.
|
artikel
|
| 46 |
Tyrosine kinase inhibitors in the treatment of systemic mastocytosis
|
Ustun, Celalettin
|
|
2011
|
35 |
9 |
p. 1143-1152
10 p.
|
artikel
|
Tijdschrift beschrijving